Valuation : Cogstate Limited

Market Cap 51Cr 37Cr 32Cr 30Cr 27Cr 51Cr 3.51TCr 354.46Cr 136.42Cr 1.78TCr 137.74Cr 134.73Cr 5.65TCr P/E 2027 *
24x
P/E 2028 * 19.6x
Enterprise Value 45Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3.08TCr 311.58Cr 119.92Cr 1.56TCr 121.08Cr 118.43Cr 4.97TCr EV / Sales 2027 *
4.2x
EV / Sales 2028 * 3.57x
Free-Float
56.23%
Yield 2027 *
1.75%
Yield 2028 * 2.12%
1 day-0.33%
1 week-2.91%
Current month-2.60%
1 month+11.11%
3 months+9.09%
6 months+32.74%
Current year+32.74%
1 week 2.95
Extreme 2.95
3.13
1 month 2.62
Extreme 2.62
3.23
Current year 2.01
Extreme 2.01
3.23
1 year 1.75
Extreme 1.75
3.23
3 years 0.8
Extreme 0.795
3.23
5 years 0.8
Extreme 0.795
3.23
10 years 0.16
Extreme 0.155
3.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Buy

Director

3,600 0.0021%
20/05/26 Buy

Director

430 0.0003%
15/04/26
Myer & Myer Pty Ltd.
SellCompany 99,74,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-2.91%+68.07%+95.44% 37Cr
+0.41%-5.15%-3.65%+10.43% 4.61TCr
-2.08%-3.57%+402.72%+533.09% 4.36TCr
+0.12%-5.27%+39.94%+20.50% 4.24TCr
-2.62%-5.76%+8.88%+77.44% 3.89TCr
-1.26%-3.37%+11.87%+40.55% 3.22TCr
+0.16%-3.65% - - 1.72TCr
-0.54%-1.72%+22.34%+115.10% 1.63TCr
+0.51%-2.04%+11.31%+31.49% 1.43TCr
-1.92%-6.94%+78.12%+36.68% 1.3TCr
Average -0.77%-4.43%+71.06%+106.75% 2.64TCr
Weighted average by Cap. -0.90%-5.04%+86.50%+128.45%

Financials

2027 *2028 *
Net sales 11Cr 7.68Cr 6.6Cr 6.23Cr 5.68Cr 11Cr 734.05Cr 74Cr 29Cr 372.32Cr 29Cr 28Cr 1.18TCr 12Cr 8.75Cr 7.52Cr 7.1Cr 6.47Cr 12Cr 836.31Cr 85Cr 33Cr 424.19Cr 33Cr 32Cr 1.35TCr
Net income 2.17Cr 1.56Cr 1.34Cr 1.26Cr 1.15Cr 2.15Cr 148.86Cr 15Cr 5.79Cr 76Cr 5.85Cr 5.72Cr 239.83Cr 2.65Cr 1.9Cr 1.63Cr 1.54Cr 1.4Cr 2.63Cr 181.65Cr 18Cr 7.07Cr 92Cr 7.13Cr 6.98Cr 292.65Cr
Net Debt -6.19Cr -4.44Cr -3.82Cr -3.6Cr -3.28Cr -6.13Cr -424.24Cr -43Cr -17Cr -215.18Cr -17Cr -16Cr -683.47Cr -7.56Cr -5.42Cr -4.66Cr -4.4Cr -4.01Cr -7.49Cr -518.36Cr -52Cr -20Cr -262.92Cr -20Cr -20Cr -835.1Cr
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
11/26/11 A$3.000 -0.33% 67,032
10/26/10 A$3.010 -2.90% 1,82,365
09/26/09 A$3.100 +1.64% 4,36,334
08/26/08 A$3.050 +1.67% 6,48,703
07/26/07 A$3.000 -2.91% 1,98,402
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.010AUD
Average target price
3.570AUD
Spread / Average Target
+18.60%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!